Terns Pharmaceuticals Inc (TERN)
5.44
+0.15
(+2.84%)
USD |
NASDAQ |
May 03, 16:00
5.435
0.00 (0.00%)
After-Hours: 20:00
Terns Pharmaceuticals Total Assets (Quarterly): 268.52M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 268.52M |
| September 30, 2023 | 271.69M |
| June 30, 2023 | 289.70M |
| March 31, 2023 | 301.28M |
| December 31, 2022 | 287.03M |
| September 30, 2022 | 192.59M |
| June 30, 2022 | 144.86M |
| March 31, 2022 | 156.67M |
| Date | Value |
|---|---|
| December 31, 2021 | 168.07M |
| September 30, 2021 | 179.89M |
| June 30, 2021 | 188.01M |
| March 31, 2021 | 199.24M |
| December 31, 2020 | 92.29M |
| September 30, 2020 | 17.41M |
| December 31, 2019 | 23.90M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
17.41M
Minimum
Sep 2020
301.28M
Maximum
Mar 2023
185.41M
Average
188.01M
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| Viking Therapeutics Inc | 967.52M |
| Eli Lilly and Co | 63.94B |
| Pfizer Inc | 226.50B |
| Amgen Inc | 92.98B |
| Madrigal Pharmaceuticals Inc | 640.55M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 13.15M |
| Shareholders Equity (Quarterly) | 255.37M |